RIMONDI, Erika
 Distribuzione geografica
Continente #
NA - Nord America 4.845
AS - Asia 2.261
EU - Europa 1.527
SA - Sud America 405
AF - Africa 44
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 9.090
Nazione #
US - Stati Uniti d'America 4.748
SG - Singapore 957
CN - Cina 620
IT - Italia 426
BR - Brasile 345
DE - Germania 249
HK - Hong Kong 230
PL - Polonia 210
UA - Ucraina 173
GB - Regno Unito 150
VN - Vietnam 125
TR - Turchia 118
RU - Federazione Russa 71
FI - Finlandia 64
ID - Indonesia 58
SE - Svezia 53
CA - Canada 51
IN - India 35
MX - Messico 31
AR - Argentina 27
FR - Francia 24
ZA - Sudafrica 23
BD - Bangladesh 21
ES - Italia 21
JP - Giappone 19
NL - Olanda 19
BE - Belgio 17
CZ - Repubblica Ceca 14
IQ - Iraq 13
LT - Lituania 12
AT - Austria 10
UZ - Uzbekistan 10
PK - Pakistan 9
MA - Marocco 7
VE - Venezuela 7
EC - Ecuador 6
KG - Kirghizistan 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
DO - Repubblica Dominicana 5
IL - Israele 5
AU - Australia 4
AZ - Azerbaigian 4
JO - Giordania 4
UY - Uruguay 4
CO - Colombia 3
EG - Egitto 3
IR - Iran 3
TN - Tunisia 3
AO - Angola 2
BG - Bulgaria 2
BO - Bolivia 2
DZ - Algeria 2
GE - Georgia 2
HN - Honduras 2
IE - Irlanda 2
JM - Giamaica 2
KE - Kenya 2
MY - Malesia 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
SR - Suriname 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DM - Dominica 1
EU - Europa 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
TJ - Tagikistan 1
Totale 9.090
Città #
Ashburn 545
Fairfield 533
Singapore 512
Woodbridge 487
Houston 281
Beijing 238
Santa Clara 234
Seattle 230
Hong Kong 228
Chandler 218
Warsaw 208
Ann Arbor 203
Wilmington 197
Dallas 192
Jacksonville 189
Cambridge 187
Ferrara 174
Los Angeles 94
New York 87
Munich 78
Izmir 64
Princeton 59
Jakarta 52
Ho Chi Minh City 46
Nanjing 46
San Diego 42
Milan 40
São Paulo 40
Boardman 35
Shanghai 34
Bologna 24
London 24
Buffalo 23
Denver 23
Montreal 22
Hanoi 21
Nanchang 20
Falls Church 19
Tokyo 18
Chicago 17
Johannesburg 17
Tianjin 17
Boston 16
Brussels 16
Hefei 16
Shenyang 16
Turku 16
Dearborn 15
Dong Ket 15
Mexico City 15
Poplar 15
Brooklyn 14
The Dalles 14
Chennai 13
Moscow 13
Rome 13
Frankfurt am Main 12
Nuremberg 12
Rio de Janeiro 12
Atlanta 11
Ferrara di Monte Baldo 11
Manchester 11
Toronto 11
Brno 10
Orem 10
San Francisco 10
Tashkent 10
Ankara 9
Auburn Hills 9
Campinas 9
Hebei 9
Jiaxing 9
San Mateo 9
Stockholm 9
Bremen 8
Changsha 8
Columbus 8
Council Bluffs 8
Falkenstein 8
Norwalk 8
Secaucus 8
Zhengzhou 8
Guangzhou 7
Kunming 7
Mountain View 7
Aprilia 6
Baghdad 6
Bishkek 6
Haiphong 6
Helsinki 6
Jinan 6
Lappeenranta 6
Phoenix 6
Calgary 5
Charlotte 5
Forlì 5
Mumbai 5
New Delhi 5
Ningbo 5
Orange 5
Totale 6.376
Nome #
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 241
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 236
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 232
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 215
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 210
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 207
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 198
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 196
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 188
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 186
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 184
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 183
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 177
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 177
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions 174
Factors Predictive of Double Anterior Chamber Formation Following Deep Anterior Lamellar Keratoplasty 171
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 169
A novel endovenous scaffold for the treatment of chronic venous obstruction in a porcine model: Histological and ultrastructural assessment 165
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL 159
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL). 159
Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema 157
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 153
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 151
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 147
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 145
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 144
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 144
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1 142
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 142
Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study 139
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 136
Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin: Letter to the editor 134
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 131
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 121
TRAIL Activates a Caspase 9/7-Dependent Pathway in Caspase 8/10-Defective SK-N-SH Neuroblastoma Cells with Two Functional End Points: Induction of Apoptosis and PGE2 Release 119
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 117
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 112
Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Show a Long-term Stability in the Breast Milk of Mothers of Preterm Infants 112
Role of vitamin D in the pathogenesis of atheromatosis 112
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 109
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry 107
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 107
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 106
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 105
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 103
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 102
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 102
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 97
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 95
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 94
null 92
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 90
null 90
null 90
null 88
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 86
null 86
null 83
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 76
null 76
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts 73
null 69
MitoQ is able to modulate apoptosis and inflammation 69
Ultrastructural Alterations of Grafted Corneal Buttons: The Anatomic Basis for Stromal Peeling Along a Natural Plane of Separation 68
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 68
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 66
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 65
The role of the mTOR pathway in diabetic retinopathy 61
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 58
null 55
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 44
null 44
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 43
null 42
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 36
NOVA2 expression in pituitary gland and in functioning and non-functioning pituitary adenomas: a preliminary study 29
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 11
Totale 9.270
Categoria #
all - tutte 45.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.047


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021573 0 0 0 0 0 118 57 101 39 133 81 44
2021/2022615 28 54 25 21 56 48 56 37 21 55 60 154
2022/2023523 58 32 23 59 77 74 34 46 71 2 29 18
2023/2024375 33 39 13 12 20 57 16 41 1 23 16 104
2024/20251.604 42 30 132 90 210 126 56 83 306 146 218 165
2025/20262.668 463 283 421 560 693 248 0 0 0 0 0 0
Totale 9.270